1. Quality assurance process within the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial for the fusion of electroanatomical mapping and radiotherapy planning imaging data in cardiac radioablation
- Author
-
Michael Mayinger, Judit Boda-Heggemann, Felix Mehrhof, David Krug, Stephan Hohmann, Jingyang Xie, Stefanie Ehrbar, Boldizsar Kovacs, Roland Merten, Melanie Grehn, Adrian Zaman, Jens Fleckenstein, Lena Kaestner, Daniel Buergy, Boris Rudic, Anne Kluge, Leif-Hendrik Boldt, Jürgen Dunst, Hendrik Bonnemeier, Ardan M. Saguner, Nicolaus Andratschke, Oliver Blanck, and Achim Schweikard
- Subjects
Electroanatomical mapping ,Radiotherapy planning ,Cardiac radioablation ,Quality assurance ,CARDIO-RT ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
A novel quality assurance process for electroanatomical mapping (EAM)-to-radiotherapy planning imaging (RTPI) target transport was assessed within the multi-center multi-platform framework of the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial. A stand-alone software (CARDIO-RT) was developed to enable platform independent registration of EAM and RTPI of the left ventricle (LV), based on pre-generated radiotherapy contours (RTC). LV-RTC were automatically segmented into the American-Heart-Association 17-segment-model and a manual 3D-3D method based on EAM 3D-geometry data and a semi-automated 2D-3D method based on EAM screenshot projections were developed. The quality of substrate transfer was evaluated in five clinical cases and the structural analyses showed substantial differences between manual target transfer and target transport using CARDIO-RT.
- Published
- 2023
- Full Text
- View/download PDF